| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/05/2009 | CA2694504A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | CA2694462A1 Thiophosphi(o)nic acid derivatives and their therapeutical applications |
| 02/05/2009 | CA2694362A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 02/05/2009 | CA2694325A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | CA2694276A1 Monoamide derivatives as orexin receptor antagonists |
| 02/05/2009 | CA2693820A1 2-aza-bicyclo[3.3.0]octane derivatives |
| 02/05/2009 | CA2693817A1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 02/05/2009 | CA2692975A1 Stable liquid pharmaceutical composition based on trazodone |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | CA2683807A1 Novel combinations of neramexane for the treatment of neurodegenerative disorders |
| 02/04/2009 | EP2020414A1 spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020405A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 02/04/2009 | EP2020240A1 Methods and substances for the treatment of Alzheimer's |
| 02/04/2009 | EP2020233A2 Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases |
| 02/04/2009 | EP2020230A1 Combination of at least two 5-HT6-Ligands |
| 02/04/2009 | EP2020229A1 Multiparticulate modified release composition |
| 02/04/2009 | EP2019834A1 Ectonucleotidase inhibitors |
| 02/04/2009 | EP2019831A1 Nicotinic acetylcholine receptor ligands 101 |
| 02/04/2009 | EP2019829A1 N- ( 2-thiazolyl) -amide derivatives as gsk-3 inhibitors |
| 02/04/2009 | EP2019828A1 N- (2-thiazolyl) -amide derivatives as gsk-3 inhibitors |
| 02/04/2009 | EP2019586A2 Acute pain medications based on fast acting diclofenac-opioid combinations |
| 02/04/2009 | EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 02/04/2009 | CN101360745A 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors |
| 02/04/2009 | CN101360742A Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 02/04/2009 | CN101360738A Compositions and methods for modulating gated ion channels |
| 02/04/2009 | CN101360737A 2-amino-5-piperidinylimidazolone compounds and use thereof for (insert beta symbol)-secretase modulation |
| 02/04/2009 | CN101360733A Dnt-fumarate and methods of preparation thereof |
| 02/04/2009 | CN101360722A Novel 2-aminopyrimidine derivatives and their use |
| 02/04/2009 | CN101360721A Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use |
| 02/04/2009 | CN101360720A Novel 2-aminopyrimidinone derivatives and their use |
| 02/04/2009 | CN101360716A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia |
| 02/04/2009 | CN101360714A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 02/04/2009 | CN101360698A Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 02/04/2009 | CN101360504A Quetiapine in a controlled release formulation |
| 02/04/2009 | CN101360501A Treatment of substance abuse |
| 02/04/2009 | CN101360499A Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases |
| 02/04/2009 | CN101360489A Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 02/04/2009 | CN101357915A Diazabicyclic central nervous system active agents |
| 02/04/2009 | CN101357227A Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 02/04/2009 | CN101357225A Preparation method of medicine for treating elderly cerebral dysfunction |
| 02/04/2009 | CN101357171A Decoction for treating sleep disorder |
| 02/04/2009 | CN101357170A Traditional Chinese medicine composition with blood-promoting and mind-easing function |
| 02/04/2009 | CN101357162A Traditional Chinese medicine capable of inducing menstruation and removing bloodstasis |
| 02/04/2009 | CN101357161A External medicine for treating vascular headache and preparation method thereof |
| 02/04/2009 | CN101357160A Traditional Chinese medicine formulation for treating insomnia |
| 02/04/2009 | CN101357150A Method for separating and purifying Qingyangshenylycosides from Qingyangsheny |
| 02/04/2009 | CN101357149A Cynanchum otophyllum schneid dispersible tablets and preparation method thereof |
| 02/04/2009 | CN101356998A Filter tip produced by tea-leaf for reducing dependency to tobacco and toxic properties |
| 02/04/2009 | CN100457778C Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/04/2009 | CN100457746C Method for the preparation of escitalopram |
| 02/04/2009 | CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457732C Method for preparing ropinirole |
| 02/04/2009 | CN100457731C Benzamide modulators of metabotropic glutamate receptors |
| 02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 02/04/2009 | CN100457182C Behavior chemotherapy |
| 02/04/2009 | CN100457171C A preparation method of medicine for treating hemiparalysis caused by apoplexy |
| 02/04/2009 | CN100457144C Compound capsule of Chinese date kernel, and preparation method |
| 02/04/2009 | CN100457131C Dripping pills of erigeron breviscapus and its preparation method |
| 02/04/2009 | CN100457129C Blood-block unlock freeze-dried powder injection(including special solvent), technique and adaptive disease |
| 02/04/2009 | CN100457124C Therapeutic agents |
| 02/04/2009 | CN100457122C Medicine containing trivalent chromium ions for prevention and/or treatment of amyloidosis |
| 02/04/2009 | CN100457110C Stable medical freeze dried preparation of tetraodotoxin |
| 02/04/2009 | CN100457107C Pharmaceutical preparation containing the active substance taken as heroin and its utilization in a method for treating opiate addiction |
| 02/04/2009 | CN100457105C Bulley aconitne transdermal paster |
| 02/04/2009 | CN100457095C Improved transdermal therapeutic system for treatment of Parkinson's disease |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485669 Blockade of sodium channels by phenol derivatives |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | US7485654 Corneal perception recovery drug containing amide compound |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485640 e.g. 2'-fluoro-5'-(7-methyl-8-oxo-7,8-dihydroimidazo[1,2-a]pyrazin-3-yl)-biphenyl-2-carbonitrile; anticonvulsant |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485635 e.g. Methyl 3-[8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidzao[1,2-a][1,4]benzodiazepine-4-yl]propanoate; GABAA (gamma aminobutiric acid) receptor antagonist; sedative-hypnotic, anxiolytic, muscle relaxant and anticonvulsant; anesthesia |
| 02/03/2009 | US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485616 Methods of investigating, diagnosing, and treating amyloidosis |
| 02/03/2009 | US7485449 Nucleic acids encoding sodium channel scn3a alpha subunits |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2538905C Withanamide glycoside and compositions and methods of use thereof |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2410554C Use of (+)-.alpha. -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis |
| 02/03/2009 | CA2390463C 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 02/03/2009 | CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof |